Market Overview

Deutsche Bank Reiterates Hold, $12 PT On Targacept


In a note out today, Deutsche Bank reiterated a hold rating and $12 price target on biotech firm Targacept (Nasdaq: TRGT). The price target implies roughly 50% upside from current levels. Deutsche Bank said downside in the stock is buffered by the company's $7 per share in cash.

Posted-In: Analyst Color News Price Target Reiteration FDA Intraday Update Markets Analyst Ratings


Related Articles (TRGT)

View Comments and Join the Discussion!